NCAM1 and glioblastoma: CD16 immunostaining of NK cells was also performed, and although a few CD56dim and CD16+ subsets of NK cells could be observed, it appeared that CD56+ CD16− NK cells were more dominant in GBM tissues (Fig. 1d).